NEW YORK (Reuters Health) - On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows. PSA is a marker for prostate cancer risk when ...

Dye binds to proteins altered by prostate cancer fo form PSA. Two of the most commonly used classes of medication—statins and nonsteroidal anti-inflammatory drugs (NSAIDs)—may compromise already ...

Hemodilution from increased circulating plasma volumes could explain why obese men with prostate cancer have lower serum PSA levels than non-obese men with the malignancy, according to researchers. A ...

Vitamin D3 and boron may support prostate health by influencing hormone balance, immune function, and cell growth. Both ...

As little as 1 mg/day of finasteride can seriously distort results of prostate-specific antigen (PSA) testing, a study shows. That’s the dosage of Propecia used by more than 4 million men to treat ...

Transdermal estradiol patches — the same ones used to curb menopause symptoms in women — are an effective alternative to luteinizing hormone–releasing hormone agonists to lower PSA levels in men with ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...

Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...